EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Semaglutide and Taste in Women With Obesity and Polycystic Ovary Syndrome: A Randomized Placebo-Controlled Study

Mojca Jensterle iD, Jernej Kovac, Andrej Vovk, Simona Ferjan iD, Saba Battelino, Tadej Battelino iD, Andrej Janez iD

The Journal of Clinical Endocrinology & Metabolism · 18.12.2025 · 111 (1) · e270-e280

DOI: 10.1210/clinem/dgaf278 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 09.05.2025. Verfasst von Mojca Jensterle und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Diabetes and Metabolic Diseases, Division of Internal Medicine, University Medical Centre Ljubljana, Ljubljana SI-1000, …. Hauptthemen laut MEDLINE: Obesity, Polycystic Ovary Syndrome, Glucagon-Like Peptides, Taste. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Slovenian Research and Innovation Agency, University Medical Centre Ljubljana.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Relationship between obesity and the sense of taste is complex, with many inconsistent and conflicting findings that are largely methodology dependent. The impact of glucagon-like peptide-1 analogues on taste remains largely unaddressed.

Methods

In this 16-week, single-blinded, placebo-controlled study, 30 women with polycystic ovary syndrome (PCOS), aged 33.7 ± 6.1 years with a body mass index of 36.4 ± 4.4 kg/m2 were randomized to semaglutide 1.0 mg once weekly or placebo. Change in taste recognition was assessed by 16 strips impregnated with 4 different concentrations of the 4 basic tastes. Tongue biopsies were performed for gene expression analysis. Brain responses to visual cues of sweet and savory foods and to sweet solution dripping on the tongue were evaluated by functional magnetic resonance imaging.

Results

Semaglutide improved overall taste recognition score from 11.9 ± 1.9 points to 14.4 ± 1.0 points, with an estimated treatment difference of 2.5 points (95% CI, 1.7-3.3). The genes EYA, PRMT8, CRLF1, and CYP1B1, which are associated with taste signaling transduction pathways, neural plasticity, and renewal of taste buds, showed differential RNA expression by a multi-tiered analytical pipeline. Semaglutide decreased activation of putamen in response to visual food cues and increased activity in the angular gyrus of the parietal cortex in response to sweet solution after meal intake (semaglutide vs placebo, P < .001).

Conclusion

In women with obesity and PCOS, semaglutide improved an overall taste recognition score, altered RNA expression in the tongue and modified brain activity in response to sweet and savory food cues and to tasting sweet solution.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ObesityPolycystic Ovary SyndromeGlucagon-Like PeptidesTasteHumansFemaleAdultSingle-Blind MethodMagnetic Resonance ImagingYoung AdultTongueBrainGlucagon-Like Peptide 1Semaglutide

Stichwörter der Autor:innen

fMRIobesitysemaglutidetaste recognitiontongue biopsy

Substanzen

Glucagon-Like PeptidesGlucagon-Like Peptide 1Semaglutide

Autor:innen und Institutionen

  • Department of Endocrinology, Diabetes and Metabolic Diseases, Division of Internal Medicine, University Medical Centre Ljubljana, Ljubljana SI-1000, Slovenia.
  • Faculty of Medicine, University of Ljubljana, Ljubljana SI-1000, Slovenia.
  • Department of Endocrinology, Diabetes and Metabolism, University Children's Hospital, University Medical Centre Ljubljana, Ljubljana SI-1000, Slovenia.
  • Department of Otorhinolaryngology and Cervicofacial Surgery, University Medical Centre Ljubljana, Ljubljana SI-1000, Slovenia.

ORCID-Profile: Mojca Jensterle, Simona Ferjan, Tadej Battelino, Andrej Janez

Förderung

  • Slovenian Research and Innovation Agency
  • University Medical Centre Ljubljana

Zitieren

APA

Jensterle, M., Kovac, J., Vovk, A., Ferjan, S., Battelino, S., Battelino, T., & Janez, A. (2025). Semaglutide and Taste in Women With Obesity and Polycystic Ovary Syndrome: A Randomized Placebo-Controlled Study. The Journal of Clinical Endocrinology & Metabolism, 111(1), e270-e280. https://doi.org/10.1210/clinem/dgaf278

Vancouver

Jensterle M, Kovac J, Vovk A, Ferjan S, Battelino S, Battelino T, et al. Semaglutide and Taste in Women With Obesity and Polycystic Ovary Syndrome: A Randomized Placebo-Controlled Study. The Journal of Clinical Endocrinology & Metabolism. 2025;111(1):e270-e280. doi:10.1210/clinem/dgaf278

BibTeX
@article{Jensterle2025,
  author = {Jensterle, Mojca and Kovac, Jernej and Vovk, Andrej and Ferjan, Simona and Battelino, Saba and Battelino, Tadej and Janez, Andrej},
  title = {Semaglutide and Taste in Women With Obesity and Polycystic Ovary Syndrome: A Randomized Placebo-Controlled Study},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  volume = {111},
  number = {1},
  pages = {e270--e280},
  doi = {10.1210/clinem/dgaf278}
}
Kostenlos starten →